Financials

  • Market Capitalization 113.26 M
  • Employee 130
  • Founded 2016
  • CEO N/A
  • Website www.nautilus.bio
  • Headquarter Washington, United States
  • FIGI BBG00W7G4M12
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-4.15
Rapporto prezzo/fatturato

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
3872
ANIX
Anixa Biosciences, Inc. - Common Stock
3.48 USD-3.33%-4.92%0.00%+17.57%118.40 M USD
3874
RANI
Rani Therapeutics Holdings, Inc. - Class A Common Stock
0.84 USD-1.18%-5.62%-1.18%+68.00%117.09 M USD
3893
SEER
Seer, Inc. - Class A Common Stock
1.98 USD-1.49%-3.88%-4.35%-3.41%109.64 M USD
3897
ONCY
Oncolytics Biotech Inc. - Common Stock
0.86 USD+1.18%+2.38%+13.16%-17.31%109.66 M USD

Notizie